Wednesday 18 October 2017
Contact US    |    Archive
PR
5 days ago

Ionis Pharmaceuticals Initiates Clinical Study of IONIS-MAPT Rx in Patients with Alzheimer s Disease

CARLSBAD, Calif., Oct. 13, 2017 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today ann

Read on the original site


For the Record

- Latimes
Hashtags:   

Ionis

 | 

Pharmaceuticals

 | 

Initiates

 | 

Clinical

 | 

Study

 | 

IONIS

 | 

MAPT

 | 

Patients

 | 
Most Popular (6 hours)

The life of Sissi

- en.gmw.cn

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries